MedX Health Corp
MDX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.01% | -2.27% | 175.20% | -19.90% | -55.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.01% | -2.27% | 175.20% | -19.90% | -55.44% |
| Cost of Revenue | 42.22% | -20.36% | 73.94% | 21.76% | -62.50% |
| Gross Profit | -68.41% | 40.08% | 3,386.67% | -48.88% | -46.40% |
| SG&A Expenses | 22.16% | 65.32% | -48.82% | -49.78% | -14.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.06% | 43.81% | -28.04% | -39.89% | -18.82% |
| Operating Income | -25.16% | -50.37% | 49.34% | 42.54% | 8.13% |
| Income Before Tax | -40.47% | -61.87% | -78.69% | 50.09% | 34.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -40.47% | -61.87% | -78.69% | 50.09% | 34.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.47% | -61.87% | -78.69% | 50.09% | 34.10% |
| EBIT | -25.16% | -50.37% | 49.34% | 42.54% | 8.13% |
| EBITDA | -25.63% | -52.67% | 48.26% | 43.92% | 8.07% |
| EPS Basic | -26.92% | -57.69% | -52.63% | 64.81% | 53.57% |
| Normalized Basic EPS | -25.00% | -62.50% | 25.00% | 64.71% | 54.29% |
| EPS Diluted | -26.92% | -57.69% | -52.63% | 64.81% | 53.57% |
| Normalized Diluted EPS | -25.00% | -62.50% | 25.00% | 64.71% | 54.29% |
| Average Basic Shares Outstanding | 9.87% | 3.95% | 16.01% | 43.43% | 43.72% |
| Average Diluted Shares Outstanding | 9.87% | 3.95% | 16.01% | 43.43% | 43.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |